Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Drugging hijacked kinase pathways in pediatric oncology: Opportunities and current scenario
Patients treated with the more aggressive schedule were given CT-996 at an initial dose of 10 mg, which was gradually increased every three to seven days to a peak of 120 mg
Congenital IGF-1 deficiency protects from oncology research models: lessons from Laron [PMID: 37343154] Laboratory literature summary: Congenital IGF-1 deficiency protects from oncology research models: lessons from Laron syndrome
21 Evelyne M Dewulf, Patrice D Cani, Sandrine P Claus, et al
US$ 28.11
US$ 25.46
US$ 24.35
US$ 24.89
